Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Brainstorm cover art

Brainstorm

Preview
Get this deal Free with 30-day trial
Offer ends on 28 December, 2026.
Prime logo
Only ₹5/month for first 3 months.
Get 1 credit per month to use on any title of your choice.
Listen to anything from the Plus Catalogue—thousands of audiobooks, podcasts, and Audible Originals.
₹199/month after first 3 months. Cancel anytime. Renews automatically. Offer ends 28 December, 2026.
1 credit a month to use on any title to download and keep
Listen to anything from the Plus Catalogue—thousands of Audible Originals, podcasts and audiobooks
Download titles to your library and listen offline
₹199.00 per month after 30-day trial. Cancel anytime.

Brainstorm

Written by: Richard Scolyer, Garry Maddox
Narrated by: Tim Carroll, Katie Nicoll
Free with 30-day trial Free with 30-day trial

₹199.00 per month after 30-day trial. Cancel anytime.

₹199.00 per month after 30-day trial. Cancel anytime.

Buy Now for ₹649.68

Buy Now for ₹649.68

About this listen
WINNER OF ABIA AWARD FOR SOCIAL IMPACT BOOK OF THE YEAR

The incredible story of 2024 Co-Australian of the Year, Richard Scolyer, as he uses his groundbreaking melanoma science to fight his own 'incurable' diagnosis with brain cancer.

A dedicated doctor. A devastating diagnosis. A chance for a medical revolution.

Skin cancer is this country's most common cancer, and melanoma the deadliest form of it. Richard Scolyer, together with his colleagues at Melanoma Institute Australia, has dedicated years to groundbreaking research and succeeded in transforming even the most advanced cases of melanoma into a largely curable disease.

Then last year, at the peak of his life, Richard was devastated when he was diagnosed with an incurable brain cancer.

As a world-leading clinician and cancer researcher, Richard was never going to accept the status quo – including a medical approach unchanged in nearly two decades and an expectation of little more than a year to live. He instead chose to undertake world-first experimental treatment for his brain cancer, based on melanoma science. His brave decision could shorten or save his life—the only certainty is that it will push the brain cancer field forward and ultimately help save the lives of others.

This is his story.©2024 Richard Scolyer with Garry Maddox (P)2024 W. F. Howes Ltd and Allen & Unwin
Medical Physical Illness & Disease Professionals & Academics
adbl_web_anon_alc_button_suppression_t1
No reviews yet